Our medical, nursing and allied health clinicians are increasingly involved in research to improve the care of our patients. This is reflected in the breadth of our research publications.
Predicting the future burden of NAFLD and NASH
Mahady, SE; George, J
(2018), J. Hepatol., 774-775
Burden of non-alcoholic fatty liver disease in Australia
Mahady, SE; Adams, LA
(2018), J. Gastroenterol. Hepatol., 1-11
DOI: 10.1111/jgh.14270
Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia
Lew, JB; St John, DJB; Macrae, FA; Emery, JD; Ee, HC; Jenkins, MA; He, E; Grogan, P; Caruana, M; Sarfati, D; Greuter, MJE; Coupe, VMH; Canfell, K
(2018), Int. J. Cancer, 269-282
DOI: 10.1002/ijc.31314
Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part II
Knowles, SR; Keefer, L; Wilding, H; Hewitt, C; Graff, LA; Mikocka-Walus, A
(2018), Inflamm. Bowel Dis., 966-976
DOI: 10.1093/ibd/izy015
Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I
Knowles, SR; Graff, LA; Wilding, H; Hewitt, C; Keefer, L; Mikocka-Walus, A
(2018), Inflamm. Bowel Dis., 742-751
DOI: 10.1093/ibd/izx100
Predictors of Impaired Mental Health and Support Seeking in Adults With Inflammatory Bowel Disease
Knowles, S; Andrews, JM; Porter, A
(2018), Gastroenterol. Nurs., 38-46
Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors
Jeon, J; Du, MM; Schoen, RE; Hoffmeister, M; Newcomb, PA; Berndt, SI; Caan, B; Campbell, PT; Chan, AT; Chang-Claude, J; Giles, GG; Gong, J; Harrison, TA; Huyghe, JR; Jacobs, EJ; Li, L; Lin, Y; Le Marchand, L; Potter, JD; Qu, CH; Bien, SA; Zubair, N; Macinnis, RJ; Buchanan, DD; Hopper, JL; Cao, Y; Nishihara, R; Rennert, G; Slattery, ML; Thomas, DC; Woods, MO; Prentice, RL; Gruber, SB; Zheng, YY; Brenner, H; Hayes, RB; White, E; Peters, U; Hsu, L
(2018), Gastroenterology, 2152-+
Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC)
Jenkins, MA; Win, AK; Templeton, AS; Angelakos, MS; Buchanan, DD; Cotterchio, M; Figueiredo, JC; Thibodeau, SN; Baron, JA; Potter, JD; Hopper, JL; Casey, G; Gallinger, S; Le Marchand, L; Lindor, NM; Newcomb, PA; Haile, RW
(2018), Int. J. Epidemiol., 387-+
DOI: 10.1093/ije/dyy006
Revised Australian national guidelines for colorectal cancer screening: family history
Jenkins, MA; Ouakrim, DA; Boussioutas, A; Hopper, JL; Ee, HC; Emery, JD; Macrae, FA; Chetcuti, A; Wuellner, L; St John, DJB
(2018), Med. J. Aust., 455-+
DOI: 10.5694/mja18.00142
Examination of the relationship between disease activity and patient-reported outcome measures in an inflammatory bowel disease cohort
Jackson, BD; Con, D; Gorelik, A; Liew, D; Knowles, S; De Cruz, P
(2018), Intern. Med. J., 1234-1241
DOI: 10.1111/imj.13937
High rates of variation in HLA-DQ2/DQ8 testing for coeliac disease: results from an RCPAQAP pilot program
Horan, MP; Chai, SY; Munusamy, N; Tay, KH; Wienholt, L; Tye-Din, JA; Daveson, J; Varney, M; Badrick, T
(2018), J. Clin. Pathol., 900-905
Real-world outcomes of unrestricted direct-acting antiviral treatment for hepatitis C in Australia: The South Australian statewide experience
Haridy, J; Wigg, A; Muller, K; Ramachandran, J; Tilley, E; Waddell, V; Gordon, D; Shaw, D; Huynh, D; Stewart, J; Nelson, R; Warner, M; Boyd, M; Chinnaratha, MA; Harding, D; Ralton, L; Colman, A; Liew, D; Iyngkaran, G; Tse, E
(2018), J. Viral Hepatitis, 1287-1297
DOI: 10.1111/jvh.12943
Methotrexate in the Treatment of Autoimmune Hepatitis Reply
Haridy, J; Sood, S; Nicoll, A
(2018), Clin. Gastroenterol. Hepatol., 149-150
Methotrexate Therapy for Autoimmune Hepatitis
Haridy, J; Nicoll, A; Sood, S
(2018), Clin. Gastroenterol. Hepatol., 288-289
T cells in coeliac disease: a rational target for diagnosis and therapy
Hardy, MY; Tye-Din, JA
(2018), Nat. Rev. Gastroenterol. Hepatol., 583-584
Resolving incomplete single nucleotide polymorphism tagging of HLA-DQ2.2 for coeliac disease genotyping using digital droplet PCR
Hardy, MY; Ontiveros, N; Varney, MD; Tye-Din, JA
(2018), HLA, 280-288
DOI: 10.1111/tan.13219
Gluten in gluten-free food from food outlets in Melbourne: a cross-sectional study
Halmos, EP; Di Bella, CA; Webster, R; Deng, MF; Tye-Din, JA
(2018), Med. J. Aust., 42-+
DOI: 10.5694/mja17.00883
Food knowledge and psychological state predict adherence to a gluten-free diet in a survey of 5310 Australians and New Zealanders with coeliac disease
Halmos, EP; Deng, M; Knowles, SR; Sainsbury, K; Mullan, B; Tye-Din, JA
(2018), Aliment. Pharmacol. Ther., 78-86
DOI: 10.1111/apt.14791
Gluten in gluten-free manufactured foods in Australia: a cross-sectional study
Halmos, EP; Clarke, D; Pizzey, C; Tye-Din, JA
(2018), Med. J. Aust., 448-+
DOI: 10.5694/mja18.00457
Practical Dietary Recommendations for the Prevention and Management of Nonalcoholic Fatty Liver Disease in Adults
George, ES; Forsyth, A; Itsiopoulos, C; Nicoll, AJ; Ryan, M; Sood, S; Roberts, SK; Tierney, AC
(2018), Adv. Nutr., 30-40
Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study)
Friedman, AB; Brown, SJ; Bampton, P; Barclay, ML; Chung, A; Macrae, FA; McKenzie, J; Reynolds, J; Gibson, PR; Hanauer, SB; Sparrow, MP
(2018), Aliment. Pharmacol. Ther., 1092-1102
DOI: 10.1111/apt.14571
Why don't I need a colonoscopy?' A novel approach to communicating risks and benefits of colorectal cancer screening
Emery, JD; Pirotta, M; Macrae, F; Walker, JG; Qama, A; Boussioutas, A; Jenkins, M
(2018), Aust. J. Gen. Pract., 343-349
Metastatic sigmoid colon adenocarcinoma and tumour-related sarcoid reaction
De Gregorio, M; Brett, AJ
(2018), Intern. Med. J., 876-878
DOI: 10.1111/imj.13812
An exploration of genotype-phenotype link between Peutz-Jeghers syndrome and STK11: a review
Daniell, J; Plazzer, JP; Perera, A; Macrae, F
(2018), Fam. Cancer, 421-427
Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease
Christensen, B; Micic, D; Gibson, PR; Yarur, A; Bellaguarda, E; Corsello, P; Gaetano, JN; Kinnucan, J; Rao, VL; Reddy, S; Singh, S; Pekow, J; Rubin, DT
(2018), Aliment. Pharmacol. Ther., 753-762
DOI: 10.1111/apt.14525
Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' reply
Christensen, B; Gibson, PR; Rubin, DT
(2018), Aliment. Pharmacol. Ther., 1423-1424
DOI: 10.1111/apt.14638
Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety
Christensen, B; Colman, RJ; Micic, D; Gibson, PR; Goeppinger, SR; Yarur, A; Weber, CR; Cohen, RD; Rubin, DT
(2018), Inflamm. Bowel Dis., 849-860
DOI: 10.1093/ibd/izx067
Predicting response after infliximab salvage in acute severe ulcerative colitis
Choy, MC; Seah, D; Gorelik, A; An, YK; Chen, CY; Macrae, FA; Sparrow, MP; Connell, WR; Moore, GT; Radford-Smith, G; Langenberg, DR; De Cruz, P
(2018), J. Gastroenterol. Hepatol., 1347-1352
DOI: 10.1111/jgh.14072
Diagnostic scores, questionnaires, quality of life, and outcome measures in pediatric continence: A review of available tools from the International Children's Continence Society
Chase, J; Bower, W; Gibb, S; Schaeffer, A; von Gontard, A
(2018), J. Pediatr. Urol, 98-107
Examining the mediational role of psychological flexibility, pain catastrophizing, and visceral sensitivity in the relationship between psychological distress, irritable bowel symptom frequency, and quality of life
Cassar, GE; Knowles, S; Youssef, GJ; Moulding, R; Uiterwijk, D; Waters, L; Austin, DW
(2018), Psychol. Health Med., 1168-1181